You are here: Industry Insights > price hikes

News List

Bausch may have shed the Valeant name, but it still leans on price hikes fiercepharma
August 18, 2019
Bausch Healthcare may have changed its name from Valeant last year, but the company hasn’t gotten away from its often-criticized strategy of leaning on price increases, one analyst says.
Pharma still puts pricing at the top of its worry list: report fiercepharma
January 08, 2019
It may not seem as if pharma companies are biting their nails over drug prices. After all, a cohort of drugmakers made headlines last week with an annual round of January hikes. But the issue is on the top of industry worries for 2019, a new report finds.
Pharma companies break 2018 price freeze pharmaceutical-technology
January 03, 2019
On 1 January approximately 30 pharmaceutical companies raised the prices of hundreds of drugs in the US by an average of 6.3%, following a year of price freezes.
Pfizer, plotting 41 price hikes for January, returns to 'business as normal' after price-raising pause fiercepharma
November 20, 2018
Pfizer, which became the center of a drug pricing controversy this summer featuring President Donald Trump, has decided it’s ready to raise prices in early 2019.
Insulin supply chain transparency needed to prevent price hikes europeanpharmaceuticalreview
November 05, 2018
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment…
Roche halts price hikes for 2018—but only after it already raised them twice fiercepharma
July 24, 2018
Roche joined a growing list of Big Pharma companies calling a halt to drug price increases—or cutting them—after President Donald Trump's naming and shaming. But that was after the Swiss drugmaker had already put through two rounds of price hikes this yea
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze: analysts fiercepharma
July 23, 2018
Little more than a week after Pfizer drew praise from President Donald Trump for simply delaying planned price increases on 40 drugs...
Johnson & Johnson predicts 4% to 6% net price decline in pharma this year, with Remicade down by double digits in Q2 fiercepharma
July 18, 2018
With the pharmaceutical industry closely tracking pricing developments, Johnson & Johnson executives shared the drug giant's perspective after reporting second-quarter results Tuesday.
Celgene pledges to limit price hikes—or does it? fiercepharma
July 04, 2018
Last October, as pharma companies ranging from Allergan to Sanofi were vowing to control price hikes...
Pfizer raises prices on 100 drugs, its second round of hikes this year fiercepharma
July 03, 2018
President Trump may think top drugmakers are ready to step up with price cuts, but Pfizer, for one, is going the other way instead.

Previous page 1 2 Next page